Metastatic Disease: Clinical Trials

2 trials for Metastatic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Metastatic Disease: new trials by email Literature Review of Metastatic Disease trials Research Report on Metastatic Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Melanoma vaccine modified to express HLA A2/4-1BB ligand - High Risk HLA-A2+ Melanoma, Metastatic Disease
Phase 2 / Phase 3WithdrawnHadassah Medical Organization2017-03-012025-10-02
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease
Phase 3CompletedWake Forest University Health Sciences1982008-02-012021-10-20

Narrower conditions

Neoplasm Metastasis (2)  ·  Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Choroid Plexus Neoplasms (1)  ·  Craniopharyngioma (1)  ·  Ependymoma (1)  ·  Fatigue (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Glioma, Subependymal (1)  ·  Gliosarcoma (1)  ·  Medulloblastoma (1)  ·  Melanoma (1)  ·  Meningioma (1)  ·  Neuroectodermal Tumors, Primitive (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplastic Processes (2)  ·  Neuroectodermal Tumors (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Cerebral Ventricle Neoplasms (1)  ·  Meningeal Neoplasms (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Donepezil (1)

Sponsors

Hadassah Medical Organization (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (1)

Top investigators

Stephen Rapp, PhD (1)

NIH funding

U10CA081851 (1)